Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

Science 337 (6100): 1343-1348

Copyright © 2012 by the American Association for the Advancement of Science

Highly Conserved Protective Epitopes on Influenza B Viruses

Cyrille Dreyfus,1,* Nick S. Laursen,1,2,* Ted Kwaks,3 David Zuijdgeest,3 Reza Khayat,1 Damian C. Ekiert,1,{dagger} Jeong Hyun Lee,1 Zoltan Metlagel,1,{ddagger} Miriam V. Bujny,3 Mandy Jongeneelen,3 Remko van der Vlugt,3 Mohammed Lamrani,3 Hans J. W. M. Korse,3 Eric Geelen,3 Özcan Sahin,3 Martijn Sieuwerts,3 Just P. J. Brakenhoff,3 Ronald Vogels,3 Olive T. W. Li,4 Leo L. M. Poon,4 Malik Peiris,4 Wouter Koudstaal,3 Andrew B. Ward,1 Ian A. Wilson,1,5,§ Jaap Goudsmit,3,§ Robert H. E. Friesen3

Abstract: Identification of broadly neutralizing antibodies against influenza A viruses has raised hopes for the development of monoclonal antibody–based immunotherapy and "universal" vaccines for influenza. However, a substantial part of the annual flu burden is caused by two cocirculating, antigenically distinct lineages of influenza B viruses. Here, we report human monoclonal antibodies, CR8033, CR8071, and CR9114, that protect mice against lethal challenge from both lineages. Antibodies CR8033 and CR8071 recognize distinct conserved epitopes in the head region of the influenza B hemagglutinin (HA), whereas CR9114 binds a conserved epitope in the HA stem and protects against lethal challenge with influenza A and B viruses. These antibodies may inform on development of monoclonal antibody–based treatments and a universal flu vaccine for all influenza A and B viruses.

1 Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
2 Department of Molecular Biology, Gustav Wieds Vej 10C, Aarhus 8000, Denmark.
3 Crucell Vaccine Institute, Janssen Center of Excellence for Immunoprophylaxis, Archimedesweg 4-6, 2301 CA Leiden, Netherlands.
4 State Key Laboratory of Emerging Infectious Diseases and School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong, China.
5 Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.

* These authors contributed equally to this work.

{dagger} Present address: Department of Microbiology and Immunology, University of California—San Francisco, 600 16th Street, San Francisco, CA 94143, USA.

{ddagger} Present address: Lawrence Berkeley National Laboratory, Department of Bioenergy/GTL and Structural Biology, Berkeley, CA 94720, USA.

§ To whom correspondence should be addressed. E-mail: wilson{at}scripps.edu (I.A.W.); jaap.goudsmit{at}crucell.com (J.G.)

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies.
F. Krammer, N. Pica, R. Hai, I. Margine, and P. Palese (2013)
J. Virol. 87, 6542-6550
   Abstract »    Full Text »    PDF »
Structure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus Hemagglutinin.
C. Dreyfus, D. C. Ekiert, and I. A. Wilson (2013)
J. Virol. 87, 7149-7154
   Abstract »    Full Text »    PDF »
Intranasal Antibody Gene Transfer in Mice and Ferrets Elicits Broad Protection Against Pandemic Influenza.
M. P. Limberis, V. S. Adam, G. Wong, J. Gren, D. Kobasa, T. M. Ross, G. P. Kobinger, A. Tretiakova, and J. M. Wilson (2013)
Science Translational Medicine 5, 187ra72
   Abstract »    Full Text »    PDF »
Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies.
A. K. Harris, J. R. Meyerson, Y. Matsuoka, O. Kuybeda, A. Moran, D. Bliss, S. R. Das, J. W. Yewdell, G. Sapiro, K. Subbarao, et al. (2013)
PNAS 110, 4592-4597
   Abstract »    Full Text »    PDF »
Hemagglutinin homologue from H17N10 bat influenza virus exhibits divergent receptor-binding and pH-dependent fusion activities.
X. Zhu, W. Yu, R. McBride, Y. Li, L.-M. Chen, R. O. Donis, S. Tong, J. C. Paulson, and I. A. Wilson (2013)
PNAS 110, 1458-1463
   Abstract »    Full Text »    PDF »
Immunopaleontology reveals how affinity enhancement is achieved during affinity maturation of antibodies to influenza virus.
H. N. Eisen and A. K. Chakraborty (2013)
PNAS 110, 7-8
   Full Text »    PDF »
Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity.
P. S. Lee, R. Yoshida, D. C. Ekiert, N. Sakai, Y. Suzuki, A. Takada, and I. A. Wilson (2012)
PNAS 109, 17040-17045
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882